Skip to content

Size Progression of Macular Degeneration After Cataract Surgery

Size Progression of Non-Exudative Age-Related Macular Degeneration After Cataract Surgery

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01165801
Enrollment
54
Registered
2010-07-20
Start date
2002-01-31
Completion date
2010-07-31
Last updated
2010-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Age-Related Macular Degeneration

Keywords

AMD, Cataract surgery, Size of AMD, Influence of cataract surgery on AMD Size

Brief summary

The purpose of this study was to find out if in patients with non-exudative age-related macular degeneration (AMD), randomly assigned to cataract surgery, any AMD size progression or progression to exudative AMD could be detected 6 months after surgery.

Interventions

PROCEDURECataract Surgery

Fifty-four patients with cataract and non-exudative age-related macular degeneration (AMD) were randomized into an early surgery group (ES=28) with immediate cataract surgery and a control group (CO=26) where surgery was performed after six months.

Sponsors

Medical Scientific Fund of the Mayor of Vienna
CollaboratorOTHER
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients with cataract and non-exudative age-related macular degeneration

Exclusion criteria

* Patients with retinal pathologies other than AMD, exudative AMD, progressive glaucoma, myopia \> 10 diopters, panretinal laser treatment, former cataract or vitreoretinal surgery, were excluded.

Design outcomes

Primary

MeasureTime frameDescription
AMD size (defined central region of interest)at enrollment, after 6 monthsTo evaluate AMD size progression, absolute and relative differences in pixels of the ROI were cal-culated by equivalent tests.

Secondary

MeasureTime frameDescription
Functional ophthalmic assessmentsat enrollment, after 6 monthsCataract grade (LOCS-III), Visual acuity (distance/near), contrast acuity tests, Visual Function Index (VF-14)

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026